Redox Modulation of Mitochondrial Proteins in the Neurotoxicant Models of Parkinson's Disease

被引:6
作者
Sarkar, Alika [1 ,2 ]
Rasheed, Mohd Sami Ur [1 ,2 ]
Singh, Mahendra Pratap [1 ,2 ]
机构
[1] CSIR Indian Inst Toxicol Res CSIR IITR, Toxicogen & Predict Toxicol Lab, Syst Toxicol & Hlth Risk Assessment Grp, 31 Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India
[2] Acad Sci & Innovat Res AcSIR, Ghaziabad, India
关键词
PD; redox modulation; mitochondrial protein; neurotoxicant; oxidative stress; COMPLEX-I INHIBITION; TARGETED ANTIOXIDANT MITOQ; CYSTEINE-SULFINIC ACID; MPTP MOUSE MODEL; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; S-NITROSYLATION; DOPAMINERGIC-NEURONS; CELL-DEATH; INCREASED SUSCEPTIBILITY;
D O I
10.1089/ars.2022.0106
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: Mitochondrial proteins regulate the oxidative phosphorylation, cellular metabolism, and free radical generation. Redox modulation alters the mitochondrial proteins and instigates the damage to dopaminergic neurons. Toxicants contribute to Parkinson's disease (PD) pathogenesis in conjunction with aging and genetic factors. While oxidative modulation of a number of mitochondrial proteins is linked to xenobiotic exposure, little is known about its role in the toxicant-induced PD. Understanding the role of redox modulation of mitochondrial proteins in complex cellular events leading to neurodegeneration is highly relevant.Recent Advances: Many toxicants are shown to inhibit complex I or III and elicit free radical production that alters the redox status of mitochondrial proteins. Implication of redox modulation of the mitochondrial proteins makes them a target to comprehend the underlying mechanism of toxicant-induced PD.Critical Issues: Owing to multifactorial etiology, exploration of onset and progression and treatment outcomes needs a comprehensive approach. The article explains about a few mitochondrial proteins that undergo redox changes along with the promising strategies, which help to alleviate the toxicant-induced redox imbalance leading to neurodegeneration.Future Directions: Although mitochondrial proteins are linked to PD, their role in toxicant-induced parkinsonism is not yet completely known. Preservation of antioxidant defense machinery could alleviate the redox modulation of mitochondrial proteins. Targeted antioxidant delivery, use of metal chelators, and activation of nuclear factor erythroid 2-related factor 2, and combinational therapy that encounters multiple free radicals, could ameliorate the redox modulation of mitochondrial proteins and thereby PD progression.
引用
收藏
页码:824 / 852
页数:29
相关论文
共 50 条
  • [11] α-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease
    Mullin, Stephen
    Schapira, Anthony
    MOLECULAR NEUROBIOLOGY, 2013, 47 (02) : 587 - 597
  • [12] Mitochondrial alterations in Parkinson's disease human samples and cellular models
    Zilocchi, Mara
    Finzi, Giovanna
    Lualdi, Marta
    Sessa, Fausto
    Fasano, Mauro
    Alberio, Tiziana
    NEUROCHEMISTRY INTERNATIONAL, 2018, 118 : 61 - 72
  • [13] Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease
    Zhang, Jianhua
    Culp, Matilda Lillian
    Craver, Jason G.
    Darley-Usmar, Victor
    JOURNAL OF NEUROCHEMISTRY, 2018, 144 (06) : 691 - 709
  • [14] Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
    Hauser, David N.
    Hastings, Teresa G.
    NEUROBIOLOGY OF DISEASE, 2013, 51 : 35 - 42
  • [15] Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
    Pozo Devoto, Victorio M.
    Falzone, Tomas L.
    DISEASE MODELS & MECHANISMS, 2017, 10 (09) : 1075 - 1087
  • [16] Mitochondrial Proteins in the Development of Parkinson's Disease
    Zilocchi, Mara
    Fasano, Mauro
    Alberio, Tiziana
    MITOCHONDRIA IN HEALTH AND IN SICKNESS, 2019, 1158 : 17 - 44
  • [17] Mitochondrial Pathology in Parkinson's Disease
    Schapira, Anthony H. V.
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (06): : 872 - 881
  • [18] Neurotoxins as Preclinical Models for Parkinson's Disease
    Segura-Aguilar, Juan
    NEUROTOXICITY RESEARCH, 2018, 34 (04) : 870 - 877
  • [19] Mitochondrial Sirtuins in Parkinson's Disease
    He, Ling
    Wang, Jihong
    Yang, Yazhi
    Li, Jian
    Tu, Huaijun
    NEUROCHEMICAL RESEARCH, 2022, 47 (06) : 1491 - 1502
  • [20] Mitochondrial dysfunction in Parkinson's disease
    Bose, Anindita
    Beal, M. Flint
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 : 216 - 231